Inventories
Alnylam Pharmaceuticals Inventories increased by 1.6% to $84.03M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.1%, from $65.58M to $84.03M. Over 5 years (FY 2020 to FY 2025), Inventories shows relatively stable performance with a 1.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase might suggest overproduction or weakening demand, while a decrease could indicate strong sales or potential supply chain shortages.
Detailed definition
The carrying value of raw materials, work-in-process, and finished goods awaiting sale to consumers or enterprise client...
Peer comparison
Consumer electronics firms strive for high inventory turnover to mitigate the risk of rapid technological depreciation.
inventoriesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.36M | $97.90M | $86.36M | $78.52M | $88.98M | $115.49M | $128.96M | $131.88M | $100.45M | $95.77M | $89.15M | $93.99M | $83.98M | $75.99M | $78.51M | $65.58M | $71.69M | $75.38M | $82.72M | $84.03M |
| QoQ Change | — | +16.1% | -11.8% | -9.1% | +13.3% | +29.8% | +11.7% | +2.3% | -23.8% | -4.7% | -6.9% | +5.4% | -10.6% | -9.5% | +3.3% | -16.5% | +9.3% | +5.2% | +9.7% | +1.6% |
| YoY Change | — | — | — | — | +5.5% | +18.0% | +49.3% | +68.0% | +12.9% | -17.1% | -30.9% | -28.7% | -16.4% | -20.7% | -11.9% | -30.2% | -14.6% | -0.8% | +5.4% | +28.1% |
Inventories at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's inventories?
- Alnylam Pharmaceuticals (ALNY) reported inventories of $84.03M in Q1 2026.
- How has Alnylam Pharmaceuticals's inventories changed year-over-year?
- Alnylam Pharmaceuticals's inventories increased by 28.1% year-over-year, from $65.58M to $84.03M.
- What is the long-term trend for Alnylam Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's inventories has grown at a 1.9% compound annual growth rate (CAGR), from $75.20M to $82.72M.
- What does inventories mean?
- The value of products currently being manufactured or held in stock ready to be sold.